Acceptance of multiple micronutrient supplementations (MMS) and iron and folic acid supplement utilisation among pregnant and lactating women in the rural part of Ethiopia, 2022: a cross-sectional study.

Abebe, Finina; Kidanemariam, Yordanos Tadesse; Tsegaw, Menen; Birhanu, Zewdie; Abdi, Ahmednasir; Chitekwe, Stanley; Sharma, Rachana; Getachew, Hiwot et al. · BMJ Open · 2025

cross_sectional · Level IV

Where this comes from

Abstract

To assess the acceptance of multiple micronutrient supplements and current iron and folic acid supplement utilisation among pregnant and lactating women in rural Ethiopia. Community-based cross-sectional study using a mixed method. This study was carried out in five regions (Oromia, Gambela, Sidama, SNNPR (Southern Nations, Nationalities and Peoples Region) and Somali) of Ethiopia, 2022. A multistage random sampling technique was employed. A structured questionnaire was used to collect data from 410 pregnant and lactating women. A purposive sampling technique was used to select participants for the five Focused Group Discussions and fifteen Key Informant Interviews. Both bivariable and multivariable logistic regression analysis was conducted with a p value<0.05, and a 95% CI was considered statistically significant. Qualitative data were coded and analysed thematically. A total of 410 pregnant and lactating women. The overall level of iron-folic acid utilisation was 59.3%. The odds of using iron-folic acid among pregnant and lactating women in the Sidama region are significantly lower compared with Oromia (adjusted OR (AOR)=0.12, 95% CI: 0.04, 0.38). Lactating women have significantly lower odds of using iron-folic acid compared with pregnant women (AOR=0.09, 95% CI: 0.05, 0.17). Taking medication or supplements significantly increases the odds of iron-folic acid use (AOR=2.41, 95% CI: 1.16, 4.95). Recommending a new nutrition supplement significantly increases the odds of iron-folic acid use (AOR=2.38, 95% CI: 1.21, 4.68). The consumption of iron-folic acid supplements among pregnant and lactating women in Ethiopia is lower than in other studies. Factors associated with iron-folic acid utilisation include region, taking medication/supplements, recommending nutrition and being a lactating mother. To ensure accessibility, the product should be sold in all town shops, pharmacies and through home delivery. Additionally, a strategy should be developed to provide access to the product in each adjacent community centre. Awareness creation should be a priority for community members to avoid misconceptions about pregnancy-related supplements.

Medical subject headings